Paper published in a journal (Scientific congresses and symposiums)
Efficacy and safety of Everolimus plus Exemestane combinaison therapy versus monotherapy with Everolimus or Capecitabine in HR+, HER2- breast cancer : a multicenter, open-label, phase 2 trial BOLERO-6
de Boer, Richard; JERUSALEM, Guy; Hurvitz, Saraet al.
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Hurvitz, Sara
Ejlertsen, Bent
El-Hashimy, Mona
Feng, Wentao
Taran, Tetiana
Burris, Howard
Language :
English
Title :
Efficacy and safety of Everolimus plus Exemestane combinaison therapy versus monotherapy with Everolimus or Capecitabine in HR+, HER2- breast cancer : a multicenter, open-label, phase 2 trial BOLERO-6
Publication date :
November 2013
Event name :
Advanced Breast Cancer Second International Consensus Conference
